Diagnosis of adrenal adenoma: Value of central spot of high-intensity hyperintense rim sign and homogeneous isointensity to liver on gadolinium- enhanced fat-suppressed spin-echo MR images

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 2, 1999, Pages 304-310

  Boraschi, Piero ^a   Braccini, Giovanni ^a   Gigoni, Roberto ^a   Perri, Giuseppe ^a   Campatelli, Alessandro ^b   Di Vito, Alessandro ^b   Bonadio, Angelo Giuseppe ^b  

^a Cisanello National Hospital   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Adrenal gland, MR, 86.121414; Adrenal gland, neoplasms, 86.317, 86.318, 86.33; MR, contrast enhancement; MR, fat suppression; MR, tissue characterization

Indexed keywords

GADOLINIUM;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0033007215     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199902)9:2<304::AID-JMRI23>3.0.CO;2-R     Document Type: Article

References (32)

1. Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH. Adrenal masses differentiated by MR, Radiology 1986;158:81-84.
2. Dunnick NR. Adrenal imaging: current status. AJR 1990;154:927-936.
3. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179:415-418.
4. Reinig JW. MR imaging differentiation of adrenal masses: has the time finally come? Radiology 1992;185:339-340.
5. McLoughlin RF, Bilbey JN. Tumors of the adrenal gland: findings on CT and MR imaging. AJR 1994;163:1413-1418.
6. Van Erkel AR, van Gils APG, Lequin M, Kruitwagen C, Bloem JL, Falke THM. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 1994;18:432-438.
7. Singer AA, Obuchowski NA, Einstein DM, Paushter DM. Metastasis or adenoma? computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 1994;61:200-205.
8. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation numbers. AJR 1996;166:531-536.
9. Chang A, Glazer HS, Lee JKT, Ling D, Heiken JP. Adrenal gland: MR imaging. Radiology 1987;163:123-128.
10. Kier R, McCarthy S. MR characterization of adrenal masses: field strength and pulse sequence considerations. Radiology 1989;171: 671-674.
11. Baker ME, Blinder R, Spitzer C, Leight GS, Herfkens RJ, Dunnick NR. MR evaluation of adrenal masses at 1.5 T. AJR 1989;153:307-312.
12. Francis IR, Gross MD, Shapiro B, Korobkin M, Quint LE. Integrated imaging of adrenal disease. Radiology 1992;184:1-13.
13. Lee MJ, Mayo-Smith WW, Hahn PF, et al. State-of-the-art MR imaging of the adrenal gland. Radiographies 1994;14:1015-1032.
14. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992;185:345-351.
15. Ichikawa T, Ohtomo K, Uchiyama G, et al. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images. Radiology 1994;193:247-250.
16. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153: 189-194.
17. Glover GH, Schneider E. Three-point Dixon technique for true water fat decomposition with Bo inhomogeneity correction. Magn Reson Med 1991;18:371-383.
18. Simon JH, Szumowski J. Proton (fat/water) chemical shift imaging in medical magnetic resonance imaging: current status. Invest Radiol 1992;27:865-874.
19. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL. Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR 1982;139:81-85.
20. Mitnick JS, Bosniak MA, Megibow AJ, Naidich DP. Non-functioning adrenal adenomas discovered incidentally on computed tomography. Radiology 1983;148:495-499.
21. Gajraj H, Young AE. Adrenal incidentaloma. Br J Surg 1993;80:422-426.
22. Gruhn JG, Gould VE. The adrenal glands. In: Kissane JM, editor. Anderson's pathology. 9th ed. St. Louis, MO: Mosby; 1990. p1580-1625.
23. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 1993;186:705-709.
24. Bilbey JH, McLoughlin RF, Kurkjian PS, et al. MR imaging of adrenal masses: value of chemical shift imaging for distinguishing adenomas from other tumors. AJR 1995;164:637-642.
25. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995;165:91-95.
26. Mitchell DG. Chemical shift magnetic resonance imaging: application in the abdomen and pelvis. Top Magn Reson Imaging 1992;4:46-63.
27. Reinig JW, Stutley JE, Leonhardt CM, Spicer KM, Margolis M, Caldwell CB. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994;192:41-46.
28. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995;197:411-418.
29. Leroy-Willig A, Roucayrol JC, Luton JP, Courtieu J, Niesenbaum N, Louvel A. In vitro adrenal cortex lesions characterization by NMR spectroscopy. Magn Reson Imaging 1987;5:339-344.
30. Leroy-Willig A, Bittoun J, Luton JP, et al. In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content. AJR 1989;153: 771-773.
31. Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical shift MR imaging. AJR 1995;165:579-583.
32. Semelka RC, Shoenut JP, Lawrence PH, et al. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging 1993;3:337-343.